Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TPR | XYL |
|---|---|---|
| Price | $118.20 | $100.33 |
| Change today | ▲ 2.75% | ▼ 0.93% |
| Market cap | $23.57B | $23.43B |
| Return, 3 months | -17.6% | -14.1% |
| Return, year to date | -6.6% | -25.5% |
| Return, 1 year | +5.2% | -31.2% |
| P/E (TTM) | 16.3 | 23.9 |
| P/B | 34.1 | 2.2 |
| P/E percentile vs own 5y | 63rd | 0th |
| Dividend yield | 1.35% | 1.65% |
| Revenue growth (YoY, latest qtr) | +8.9% | +1.5% |
| Net profit growth (YoY) | +167.3% | +16.5% |
| Gross margin | 77.8% | 39.2% |
| Operating margin | 23.9% | 15.5% |
| Net margin | 19.1% | 11.2% |
| Return on equity | 197.1% | 9.5% |
| Analyst target vs. price | +48.1% | +51.8% |
| Analyst buy share | 93% | 64% |
| RSI (14) | 39 | 29 |
| 30-day volatility | 28.1% | 25.0% |
| Max drawdown, 1 year | -32.7% | -33.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
